pd 173074 and pd 98059

pd 173074 has been researched along with pd 98059 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Chen, E; Hu, D; Pan, Z; Tao, Y; Xie, T; Xue, D; Zhang, W; Zhu, T1

Other Studies

2 other study(ies) available for pd 173074 and pd 98059

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
Secreted klotho protein attenuates osteogenic differentiation of human bone marrow mesenchymal stem cells in vitro via inactivation of the FGFR1/ERK signaling pathway.
    Growth factors (Chur, Switzerland), 2015, Volume: 33, Issue:5-6

    Topics: Alkaline Phosphatase; Bone Marrow Cells; Calcification, Physiologic; Cell Differentiation; Cells, Cultured; Core Binding Factor Alpha 1 Subunit; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Glucuronidase; Humans; Klotho Proteins; MAP Kinase Signaling System; Mesenchymal Stem Cells; Osteogenesis; Protein Kinase Inhibitors; Pyrimidines; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 1

2015
chemdatabank.com